A drug with the SMILES O=C(NCCCN1CCOCC1)c1onc(CSc2nc3ccccc3[nH]2)c1C(=O)NCCCN1CCOCC1 has a human ether-à-go-go related gene (hERG) inhibition at 10uM of 15.867%.
A {#drug|compound!} with the {SMILES__description} {SMILES#} has a {herg_central_at_10uM__names__noun} of {herg_central_at_10uM#}{herg_central_at_10uM__units}.
O=C(NCCCN1CCOCC1)c1onc(CSc2nc3ccccc3[nH]2)c1C(=O)NCCCN1CCOCC1
O=C(NCCCN1CCOCC1)c1onc(CSc2nc3ccccc3[nH]2)c1C(=O)NCCCN1CCOCC1
3-(1H-benzimidazol-2-ylsulfanylmethyl)-4-N,5-N-bis(3-morpholin-4-ylpropyl)-1,2-oxazole-4,5-dicarboxamide